Electra Therapeutics Inc. (ETRA) vs MiMedx Group, Inc (MDXG)

Electra Therapeutics Inc. ETRA 7.87 −2.48%
MiMedx Group, Inc MDXG 3.19 −1.85%

Electra Therapeutics Inc. and MiMedx Group, Inc are both Biotechnology companies. Electra Therapeutics Inc. and MiMedx Group, Inc are of similar size ($506.5M and $474.3M).

Metric	ETRA	MDXG	Biotechnology median
P/E	—	n/m	10.64
P/S	—	1.51	9.59
P/B	—	2.17	2.15
Price to free cash flow	—	24.08	26.07
EV/EBITDA	—	n/m	0.65
EV/Sales	—	1.17	9.45
Earnings yield	—	(4.12%)	(34.69%)
Free cash flow yield	—	4.15%	(24.02%)

Metric	ETRA	MDXG	Biotechnology median
Gross margin	—	77.29%	65.59%
Operating margin	—	(8.28%)	0.00%
Net margin	—	(6.32%)	0.00%
Free cash flow margin	—	6.26%	0.00%
Return on equity	—	(8.53%)	(51.96%)
Return on assets	—	(6.58%)	(46.06%)
Return on invested capital	—	(17.40%)	0.00%

Metric	ETRA	MDXG	Biotechnology median
Revenue growth (TTM)	—	(22.80%)	4.59%
EPS growth (last fiscal year)	—	14.29%	29.88%
Revenue growth, 5-year CAGR	—	11.02%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ETRA	MDXG	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	4.35	4.86
Net debt to EBITDA	—	(1.88)	1.01

Metric	ETRA	MDXG	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	ETRA	MDXG	Biotechnology median
Market cap	506.53m	474.26m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack